Входя на эту страницу, Вы подтверждаете, что являетесь  медицинским работником.

Status message

Not the entire site translated, but only to "Magazine"

Psychiatric Services Strategies During the COVID-19 Pandemic

S.N. Mosolov

Moscow Research Institute of Psychiatry – a branch of the FSBI “National Medical Research Center for Psychiatry and Addiction named after V.P. Serbian” Ministry of Health of Russian Federation, Moscow, Russia

Summary.

The COVID-19 pandemic and unpreceded measures taken by the government to contain COVID-19 outbreak, quarantine and isolation, the growing fear in the community due to publication of rumors and misinformation in social networks as well as concerns for the patients with mental illness represent the new challenges for psychiatry as a medical specialty that require urgent new organizational and treatment strategies. The primary goal is to optimize patient flow by separating people requiring psychological support and psychiatric care, and provide these services remotely (hotlines and telemedicine consultations). This overview proposes a roadmap for the urgent and preventive organizational and treatment mesures, based on the experience of other countries where COVID-19 has massively spread, as well as practical recommendations on temporary reorganization of the mental health services for providing effective psychological and psychotherapeutic support to the most vulnerable groups of the population, including frontline health professionals fighting COVID-19, and the management of mentally-ill patients with severe acute respiratory syndrome (SARS). Special consideration has been given to psychopharmacotherapy tactics in such patients with a review of potential adverse effects and drug interactions primarily affecting respiratory system.

Contact: profmosolov@mail.ru
https://orcid.org/0000-0002-5749-3964

CITATION: Mosolov S.N. Psychiatric Services Strategies During the COVID-19 Pandemic // Sovrem. ter. psih. rasstrojstv. – 2020. – № 2. – DOI: 10.21265/PSYPH.2020.53.59536

References

1.    Coronavirus disease (COVID-19) Pandemic. Geneva: World Health Organization, March 23, 2020. – Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (accessed April 4, 2020). 
2.    Schwartz B.J. New APA survey on public anxiety over COVID-19 // High Anxiety in America Over COVID-19 – Medscape. – Mar 28, 2020. 
3.    Brooks S.K., Webster R.K., Smith L.E. et al. The psychological impact of quarantine and how to reduce it: Rapid review of the evidence // Lancet. – 2020. – Vol. 395 (10227). – P. 912–920.
4.    London R.T. Is COVID-19 leading to a mental illness pandemic? Presented by ID Practitioner in MDedge Infectious disease [published online March 25, 2020]. Available at: https://www.mdedge.com/infectiousdisease/article/219612/coronavirus-upda... (accessed April 4, 2020).
5.    Aleksandrovskii Yu.A. Sotsial'no-stressovye rasstroistva // RMZh. – 1996. T. 3, № 11. – S. 689–694.
6.    Dmitrieva T.B., Aleksandrovskii Yu.A., Kekelidze Z.I. i dr. Sotsial'nyi stress i psikhicheskoe zdorov'e. M.: Vseros. ucheb.-nauch.-metodich. tsentr po nepreryvnomu meditsinskomu i farmatsevticheskomu obrazovaniyu, 2001. 248 s. 
7.    Kekelidze Z.I., Portnova A.A. Kriterii diagnostiki posttravmaticheskogo stressovogo rasstroistva // Zhurnal nevrologii i psikhiatrii imeni C.C. Korsakova. – 2009. – T. 109, № 12. – S. 4–7. 
8.    Goldberg J.F. Psychiatry’s niche role in the COVID-19 pandemic // J Clin Psychiatry. 2020. Vol. 81 (3). 20com13363.
9.    Kekelidze Z.I., Chekhonin V.P. Kriticheskie sostoyaniya v psikhiatrii. Klinicheskie i immunokhimicheskie aspekty. – M.: Gos. nauch. tsentr sotsial'noi i sudebnoi psikhiatrii imeni V.P. Serbskogo, 1997. – 362 s. 
10.    Aleksandrovskii Yu.A., Chekhonin V.P. Klinicheskaya immunologiya pogranichnykh psikhicheskikh rasstroistv. – M.: GEOTAR-Media, 2005. – 235 s.
11.    Jeste D.V., Lee E.E., Cacioppo S. Battling the modern behavioral epidemic of loneliness: Suggestions for research and interventions // JAMA Psychiatry [published online ahead of print March 4, 2020].
12.    Steptoe A., Shankar A., Demakakos P. et al. Social isolation, loneliness, and all-cause mortality in older men and women // Proc Natl Acad Sci USA. – 2013. – Vol. 110 (15). – P. 5797–5801. 
13.    Sprang G., Silman M. Posttraumatic stress disorder in parents and youth after health- related disasters // Disaster Med Public Health Prep. – 2013. – Vol. 7 (1). – P. 105–110. 
14.    China Newsweek. Collective infections of coronavirus among 50 patients and 30 health workers in one psychiatric hospital in Wuhan // Shanghai Obs. 2020. – Available at: https://www.jfdaily.com/news/detail?id=208584 (accessed Feb 17, 2020; in Chinese).
15.    Fagiolini A., Cuomo A., Frank E. COVID-19 diary from a psychiatry department in Italy // J Clin Psychiatry. – 2020. – Vol. 81 (3). – 20com13357.
16.    Sartorius N. Comorbidity of mental and physical diseases: a main challenge for medicine of the 21st century // Shanghai Arch Psychiatry. – 2013. – Vol. 25. – P. 68–69. 
17.    Seminog O.O., Goldacre M.J. Risk of pneumonia and pneumococcal disease in people with severe mental illness: English record linkage studies // Thorax. – 2013. – Vol. 68. – P. 171–176.
18.    Doarn C.R. Telemedicine and psychiatry: a natural match // mHealth. – 2018. – Vol. 4. – P. 60.
19.    Arean P.A., Hallgren K.A., Jordan J.T. et al. The use and effectiveness of mobile apps for depression: results from a fully remote clinical trial // J Med Internet Res. – 2016. – Vol. 18 (12). – e330. 
20.    Kekelidze Z.I. Printsipy okazaniya psikhologo-psikhiatricheskoi pomoshchi pri chrezvychainykh situatsiyakh // Psikhiatriya i psikhofarmakoterapiya. – 2001. – T. 3, № 4. S. 123–125. 
21.    Poyiadji N., Shahin G., Noujaim D. et al. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI // Radiology. 2020 [published online: Mar 31, 2020]. – Available at:  https://pubs.rsna.org/doi/10.1148/radiol.2020201187 (accessed 5 April, 2020).
22.    Mehta P., McAuley D.F., Brown M. et al. HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression // Lancet. – 2020. – Vol. 395 (10229). – P. 1033–1034. 
23.    Baig A.M., Khaleeq A., Ali U. et al. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanism // ACS CheNeurosci [published online ahead of print March 13, 2020].
24.    Filatov A, Sharma P, Hindi F, et al. Neurological complications of coronavirus (COVID-19): encephalopathy. // Cureus. –  Vol. 12 (3). – e7352. – DOI: 10.7759/cureus.7352 
25.    Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients // J Med Virol [published online ahead of print February 27, 2020]. 
26.    Neznanov N.G., Mosolov S.N., Ivanov M.V. Psikhofarmakoterapiya // Psikhiatriya. Natsional'noe rukovodstvo. – M.: GEOTAR-Media, 2018. – S. 1627–1736. 
27.    Biologicheskie metody terapii psikhicheskikh rasstroistv (dokazatel'naya meditsina – klinicheskoi praktike) / pod red. S.N. Mosolova. – M.: Sotsial'no-politicheskaya mysl', 2012. – 1073 s. 
28.    Malin D.I. Pobochnoe deistvie psikhotropnykh sredstv. – M.: Vuzovskaya kniga, 2000. – 207 s. 
29.    Paul K., Walker R. Anticholinergic medications and risk of community-acquired pneumonia in elderly adults: a population-based older adults: a populations- based case-contral study // J Am Geriatr Soc. – 2015. – Vol. 63. – P. 476–485.
30.    Dublin S., Walker RL, Jackson ML, et al. Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study // J Am Geriatr Soc. 2011. Vol. 59. P. 1899–1907.
31.    Stein D.J. Pharmacotherapy of adjustment disorder: a review. // World J Biol Psychiatry. – 2018. – Vol. 19, Suppl. 1. – P. 46–52. 
32.    U.S. Food and Drug Administration. 19 décembre 2019. – Available at: https://www.fda.gov/news-events/fda-brief/fda-brief-fda-requires-new-war... (accessed April 4, 2020).
33.    Mosolov S.N. Primenenie solei litiya v psikhiatricheskoi praktike: metodich. rekomendatsii MZ SSSR. – M., 1983. – 44 s.
34.    Chan H.Y., Lai C.L., Lin Y.C. et al. Is Antipsychotic Treatment Associated With Risk of Pneumonia in People With Serious Mental Illness? The Roles of Severity of Psychiatric Symptoms and Global Functioning // J Clin Psychopharmacol. – 2019, Sep/Oct. – Vol. 39 (5). – P. 434–440. 
35.    Goodlet K.J., Zmarlicka M.T., Peckham A. Drug-drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs // SNS Spectrums. – 2018. – P. 1–26. – DOI: 10.1017/S109285291800113X
36.    Mosolov S.N., Malin D.I., Ryvkin P.V., Sychev D.A. Lekarstvennye vzaimodeistviya preparatov, primenyaemykh v psikhiatricheskoi praktike // Sovremennaya terapiya psikhicheskikh rasstroistv. – 2019. – № S1 (dopolnitel'nyi tematicheskii vypusk). – S. 1–35. 
37.    Wynn G.H., Oesterheld I.R., Cozza K.L., Armstrong S.C. Clinical Manual of Psychotropic Drug Interaction. Principles for medical practice. – APP, Washington DC, 2009. – 594 p.